Trevi Therapeutics Inc. – Underwriting Agreements

NASDAQ: TRVI
Share price (4/24/26): $14.41
Market cap (4/24/26): $1.853 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 44 pages Trevi Therapeutics, Inc. (A Delaware Corporation) 11,600,000 Shares of Common Stock Underwriting Agreement

from SCHEDULE 13D/A ~10 pages Agreement

from S-3ASR 43 pages Trevi Therapeutics, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from SCHEDULE 13D/A ~10 pages Agreement

from 8-K 42 pages Trevi Therapeutics, Inc. (A Delaware Corporation) 17,400,000 Shares of Common Stock Underwriting Agreement

from SCHEDULE 13D/A ~10 pages Agreement

from 8-K 40 pages Trevi Therapeutics, Inc. (A Delaware Corporation) 12,500,000 Shares of Common Stock Underwriting Agreement

from S-3 43 pages Trevi Therapeutics, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from 8-K 43 pages Trevi Therapeutics, Inc. (A Delaware Corporation) 14,252,670 Shares of Common Stock and Pre-Funded Warrants to Purchase 14,247,330 Shares of Common Stock Underwriting Agreement

from S-3 43 pages Trevi Therapeutics, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from S-1/A 46 pages Trevi Therapeutics, Inc. (A Delaware Corporation) [•] Shares of Common Stock Underwriting Agreement